• No results found

Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders

N/A
N/A
Protected

Academic year: 2020

Share "Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Orphan Medicinal Products for lysosomal storage disorders

References

Related documents

In order to provide an accurate numerical solution for overland flows, the model in this work uses the Roe’s approximate Riemann solver for the calculation of fluxes on

 International  Institute  for  Environment  and  Development..  Institute  of  Particle

3.2 Effect of pressure on the ozone output mixing ratio As described earlier, the target mixing ratio output of the ozone calibration source is achieved by varying the photol- ysis

We present SWING-UAV experiments performed in Ro- mania on 11 September 2014 during the Airborne ROma- nian Measurements of Aerosols and Trace gases (ARO- MAT) campaign, which

Using only R&D employees as input factors in a regional innovation performance analysis implies that the obtained performance measures represent firms’ innovation

Pos- sible sources of heterogeneity, including published year, country, number of study subjects, methods for allergen detection (skin prick test, ImmunoCAP, RAST testing, or

On the current study, the time spent by the species on feeding, courtship and resting behaviors was significantly different in the study area regarding to season,

as influencing the course of illness : discord in the parents’ marital relationship, anxiety on the part of mother and child regarding the consequences of tongue chewing, and